High MYBL2 expression and transcription regulatory activity is associated with poor overall survival in patients with hepatocellular carcinoma

High MYBL2 expression/TRA are associated with inferior OS in patients with primary HCC. Increased expression of MYBL2, LIN9, LIN52 and FOXM1 are related to higher TRA of B-Myb in HCC.